A monohydrate salt of Regorafenib, a multikinase inhibitor used in the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumors. Shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.Reference standards of Regorafenib Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Regorafenib Monohydrate [catalogue_number] => PA 18 35000 [category_ids] => ,80,71,76,75,78,70,82,89, [chemical_name] => [weight] => 500.83 [form] => C21H17ClF4N4O4 [cas] => 1019206-88-2 [pslug] => 1019206-88-2-regorafenib-monohydrate-api-standards-pa1835000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 18 35000
CAS :
Molecular Formula : C21H17ClF4N4O4
Molecular Weight : 500.83
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
